The Only Stock Warren Buffett Is Clearly Buying Right Now

Berkshire Hathaway resumed share repurchases per an SEC filing on March 4, 2026, with Warren Buffett consulted and approving the move. CEO Greg Abel—making his first major capital-allocation decision—says buybacks reflect management’s view that BRK is trading below intrinsic value amid rising oil, a weakening economy, and potential inflation resurgence. Berkshire held $373 billion in cash, cash equivalents, and short-term investments at end-2025, giving substantial dry powder to deploy. The buyback is a positive, company-specific catalyst likely to support BRK shares and signal capital-allocation discipline.

Analysis

Resumption of repurchases by Berkshire is primarily an information event rather than a cash-deployment shock — the immediate second-order impact is on per-share economics and optionality. Even modest buybacks from a large cash base produce measurable EPS/Net Asset Value accretion over 6–18 months because the numerator (earnings, deployed capital returns) compounds while the denominator (share count) contracts; that dynamic steepens returns for patient holders without changing underlying business momentum.

A less-obvious effect is market microstructure: repurchases that are executed steadily but opportunistically will reduce free float and intraday liquidity in BRK shares, concentrating price moves around macro risk events and increasing the value of being on the right side of short-term flows. For active strategies this creates tactical windows where temporary dislocations can be captured (wider spreads, predictable dealer hedging flows). It also increases the CEO’s real optionality to pursue M&A over Treasuries — buybacks set a price floor that makes future acquisitions at higher prices politically and economically easier.

Risks that would reverse upside are macro (rapidly rising rates or a liquidity squeeze that forces asset-fire sales), valuation slippage in core operating subsidiaries, or a mis-timed repurchase program that overpays into a multi-quarter market trough. Time horizon matters: expect visible impact within 3–12 months on share count and 6–24 months on GAAP/normalized EPS; a material re-rating requires either demonstrable M&A deployment or a sustained macro dislocation that allows large-scale opportunistic purchases at meaningful discounts to intrinsic value.

Key Decisions for Investors

• Long BRKB (prefer BRKB for options/liquidity): accumulate in 3 tranches on weakness (tranche sizes 40/30/30) over 6–12 months; hedge 50% of market beta with S&P futures to target 12–20% absolute return while limiting macro drawdowns. R/R: asymmetric—limited capital at risk vs potential multi-quarter EPS accretion and intrinsic-value rerating; main risk is broad market collapse.
• Pair trade: long BRKB / short SPY (beta-neutral via futures) over a 6–12 month horizon to isolate Berkshire-specific buyback/M&A alpha. Position size to target 10–15% expected excess return; largest tail risk is company-specific asset impairment causing both legs to lose.
• Tactical options trade: buy 9-month BRKB call spread (near-ATM buy / +12–18% sell) to capture upside from buyback-driven re-rating with defined downside limited to premium paid. Use this when BRKB pulls back >5% intraday to improve cost basis; reward potential 3–5x premium if catalyst materializes.
• Monitor catalyst triggers and stop-loss: if 10–15% of declared cash is deployed into M&A at >10% premium to intrinsic, trim 30–50% of long exposure and rotate into high-quality cyclicals or short-duration fixed income—this preserves gains if management shifts from buybacks to overpaying acquisitions.